Polyether ionophores: broad-spectrum and promising biologically active molecules for the control of drug-resistant bacteria and parasites

被引:154
|
作者
Kevin, Dion A., II [1 ]
Meujo, Damaris A. F. [1 ]
Hamann, Mark T. [1 ]
机构
[1] Univ Mississippi, Sch Pharm, Natl Ctr Nat Prod Res & Triton Biopharma, Oxford, MS 38677 USA
基金
美国国家卫生研究院;
关键词
antibacterial; antibiotics; antifungal; antimalarial; antiviral; carboxylic polyether; drug resistance; ionophore; polyethers; HUMAN-IMMUNODEFICIENCY-VIRUS; VIVO ANTIMALARIAL ACTIVITIES; K+/H+-ANTIPORTER NIGERICIN; IN-VITRO ACTIVITIES; TOXOPLASMA-GONDII; EIMERIA-TENELLA; PLASMODIUM-FALCIPARUM; CALCIUM IONOPHORE; STREPTOMYCES-SALVIALIS; CRYPTOSPORIDIUM-PARVUM;
D O I
10.1517/17460440802661443
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Background: As multidrug-resistant (MDR) pathogens continue to emerge, there is a substantial amount of pressure to identify new drug candidates. Carboxyl polyethers, also referred to as polyether antibiotics, are a unique class of compounds with outstanding potency against a variety of critical infectious disease targets including protozoa, bacteria and viruses. The characteristics of these molecules that are of key interest are their selectivity and high potency against several MDR etiological agents. Objective: Although many studies have been published about carboxyl polyether antibiotics, there are no recent reviews of this class of drugs. The purpose of this review is to provide the reader with an overview of the spectrum of activity of polyether antibiotics, their mechanism of action, toxicity and potential as drug candidates to combat drug-resistant infectious diseases. Conclusion: Polyether ionophores show a high degree of promise for the potential control of drug-resistant bacterial and parasitic infections. Despite the long history of use of this class of drugs, very limited medicinal chemistry and drug optimization studies have been reported, thus leaving the door open to these opportunities in the future. Scifinder and PubMed were the main search engines used to locate articles relevant to the topic presented in the present review. Keywords used in our search were specific names of each of the 88 compounds presented in the review as well as more general terms such as polyethers, ionophores, carboxylic polyethers and polyether antibiotics.
引用
收藏
页码:109 / 146
页数:38
相关论文
共 10 条
  • [1] Derivatives of the Antimalarial Drug Mefloquine Are Broad-Spectrum Antifungal Molecules with Activity against Drug-Resistant Clinical Isolates
    Montoya, Marhiah C.
    Beattie, Sarah
    Alden, Kathryn M.
    Krysan, Damian J.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2020, 64 (03)
  • [2] Analysis of the broad-spectrum potential of nitric oxide for antibacterial activity against clinically isolated drug-resistant bacteria
    Bright, Lori M. Estes
    Chug, Manjyot Kaur
    Thompson, Stephen
    Brooks, Megan
    Brisbois, Elizabeth J.
    Handa, Hitesh
    JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART B-APPLIED BIOMATERIALS, 2024, 112 (07)
  • [3] Elaborately engineered Au(I)-based AIEgens: Robust and broad-spectrum elimination abilities toward drug-resistant bacteria
    Deng, Shuangling
    Peng, Zhen
    Zhou, Fang
    Zhong, Guanqing
    Cai, Zhen
    Tang, Xiaodong
    Xu, Changhuo
    Zheng, Lei
    Tang, Ben Zhong
    Zhang, Jing
    AGGREGATE, 2024, 5 (05):
  • [4] A Supramolecular-Based Dual-Wavelength Phototherapeutic Agent with Broad-Spectrum Antimicrobial Activity Against Drug-Resistant Bacteria
    Yu, Zhi-Hao
    Li, Xingshu
    Xu, Fugui
    Hu, Xi-Le
    Yan, Jiatao
    Kwon, Nahyun
    Chen, Guo-Rong
    Tang, Tingting
    Dong, Xiaojing
    Mai, Yiyong
    Chen, Daijie
    Yoon, Juyoung
    He, Xiao-Peng
    Tian, He
    ANGEWANDTE CHEMIE-INTERNATIONAL EDITION, 2020, 59 (09) : 3658 - 3664
  • [5] A Foundation Model Identifies Broad-Spectrum Antimicrobial Peptides against Drug-Resistant Bacterial Infection
    Li, Tingting
    Ren, Xuanbai
    Luo, Xiaoli
    Wang, Zhuole
    Li, Zhenlu
    Luo, Xiaoyan
    Shen, Jun
    Li, Yun
    Yuan, Dan
    Nussinov, Ruth
    Zeng, Xiangxiang
    Shi, Junfeng
    Cheng, Feixiong
    NATURE COMMUNICATIONS, 2024, 15 (01)
  • [6] Broad-spectrum activity of membranolytic cationic macrocyclic peptides against multi-drug resistant bacteria and fungi
    Lohan, Sandeep
    Konshina, Anastasia G.
    Tiwari, Rakesh K.
    Efremov, Roman G.
    Maslennikov, Innokentiy
    Parang, Keykavous
    EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2024, 197
  • [7] ETX2514 is a broad-spectrum β-lactamase inhibitor for the treatment of drug-resistant Gram-negative bacteria including Acinetobacter baumannii
    Durand-Reville, Thomas F.
    Guler, Satenig
    Comita-Prevoir, Janelle
    Chen, Brendan
    Bifulco, Neil
    Hoan Huynh
    Lahiri, Sushmita
    Shapiro, Adam B.
    McLeod, Sarah M.
    Carter, Nicole M.
    Moussa, Samir H.
    Velez-Vega, Camilo
    Olivier, Nelson B.
    McLaughlin, Robert
    Gao, Ning
    Thresher, Jason
    Palmer, Tiffany
    Andrews, Beth
    Giacobbe, Robert A.
    Newman, Joseph V.
    Ehmann, David E.
    de Jonge, Boudewijn
    O'Donnell, John
    Mueller, John P.
    Tommasi, Ruben A.
    Miller, Alita A.
    NATURE MICROBIOLOGY, 2017, 2 (09):
  • [8] Design, synthesis, and evaluation of novel pleuromutilin aryl acrylate derivatives as promising broad-spectrum antibiotics especially for combatting multi-drug resistant gram-negative bacteria
    Li, Min
    Li, Jialin
    Li, Jingyi
    Zhang, Jie
    Zhao, Yuqing
    Li, Wenying
    Zhang, Yunfei
    Hu, Jinrong
    Xie, Xiaolin
    Zhang, Dezhu
    Li, Han
    Zhao, Qianqian
    Gao, Hong
    Liang, Chengyuan
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2023, 259
  • [9] The Trisubstituted Isoxazole MMV688766 Exerts Broad-Spectrum Activity against Drug-Resistant Fungal Pathogens through Inhibition of Lipid Homeostasis
    Puumala, Emily
    Zaslaver, Olga
    Chen, Amy
    Duncan, Dustin
    Fogal, Meea
    Shapiro, Rebecca S.
    Mazhab-Jafari, Mohammad T.
    Whitesell, Luke
    Montenegro-Burke, J. Rafael
    Robbins, Nicole
    Cowen, Leah E.
    MBIO, 2022, 13 (06):
  • [10] Effects of Broad-Spectrum Antimicrobials on Patients with Community-Acquired Pneumonia with Low Risk for Drug-Resistant Pathogens: Historical Cohort Study in Japan
    Takazono, Takahiro
    Hosogaya, Naoki
    Saito, Yoshiyuki
    Takemura, Masahiko
    Iwanaga, Naoki
    Sakamoto, Noriho
    Hirayama, Junichi
    Ueno, Rie
    Mukae, Hiroshi
    INFECTIOUS DISEASES AND THERAPY, 2025,